MolMed and Fondazione Telethon partnered to develop and manufacture gene therapy treatments for six rare genetic diseases

MolMed S.p.A.

Italy / Small-Cap Biopharma (<$1 billion)

Research Partner

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Fondazione Telethon

Italy / Non-Profit or Major Disease Foundation

Research Partner

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced